- Report
- February 2026
- 279 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 138 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 263 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 192 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 273 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 181 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 179 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 162 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 193 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 402 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 187 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 193 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- August 2025
- 180 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- May 2025
- 110 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- November 2025
- 200 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,522GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,522GBP
- Report
- May 2025
- 114 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- July 2025
- 350 Pages
Global
From €4331EUR$4,949USD£3,765GBP
- Report
- July 2025
- 350 Pages
Global
From €4331EUR$4,949USD£3,765GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more